1 |
Bostrom A, Lindman H, Swartling C, Berne B, Bergh J (2001). Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol, 59, 257-65.
DOI
ScienceOn
|
2 |
Brown GL, Curtsinger L 3rd, Brightwell JR, et al (1986). Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med, 163, 1319-24.
DOI
ScienceOn
|
3 |
Brown GL, Nanney LB, Griffen J, et al (1989). Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med, 321, 76-9.
DOI
ScienceOn
|
4 |
Cohen S (1962). Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem, 237, 1555-62.
|
5 |
Dormand EL, Banwell PE,Goodacre TE (2005). Radiotherapy and wound healing. Int Wound J, 2, 112-27.
DOI
ScienceOn
|
6 |
Duncan W, MacDougall RH, Kerr GR, Downing D (1996). Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol, 41, 203-7.
DOI
ScienceOn
|
7 |
Fenig E, Brenner B, Katz A, et al (2001). Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep, 8, 305-9.
|
8 |
Fernando IN, Ford HT, Powles TJ, et al (1996). Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol), 8, 226-33.
DOI
ScienceOn
|
9 |
Fisher J, Scott C, Stevens R, et al (2000). Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys, 48, 1307-10.
DOI
ScienceOn
|
10 |
Graham PH, Plant N, Graham JL, et al (2013). A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01. Int J Radiat Oncol Biol Phys, 86, 45-50.
DOI
ScienceOn
|
11 |
Halperin EC, Gaspar L, George S, Darr D, Pinnell S (1993). A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys, 26, 413-6.
DOI
|
12 |
Harper JL, Franklin LE, Jenrette JM, Aguero EG (2004). Skin toxicity during breast irradiation: pathophysiology and management. South Med J, 97, 989-93.
DOI
ScienceOn
|
13 |
Hemati S, Asnaashari O, Sarvizadeh M, et al (2012). Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer, 20, 1613-8.
DOI
|
14 |
Hong JP, Jung HD, Kim YW (2006a). Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg, 56, 394-8.
DOI
ScienceOn
|
15 |
Hong JP, Kim YW, Jung HD, Jung KI (2006b). The effect of various concentrations of human recombinant epidermal growth factor on split-thickness skin wounds. Int Wound J, 3, 123-30.
DOI
ScienceOn
|
16 |
Hong JP, Kim YW, Lee SK, Kim SH, Min KH (2008). The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds. Ann Plast Surg, 61, 457-62.
DOI
ScienceOn
|
17 |
Lee SW, Jung KI, Kim YW, et al (2007a). Effect of epidermal growth factor against radiotherapy-induced oral mucositis in rats. Int J Radiat Oncol Biol Phys, 67, 1172-8.
DOI
ScienceOn
|
18 |
Hymes SR, Strom EA, Fife C (2006). Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol, 54, 28-46.
DOI
ScienceOn
|
19 |
Kirova YM, Fromantin I, De Rycke Y, et al (2011). Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial. Radiother Oncol, 100, 205-9.
DOI
ScienceOn
|
20 |
Lee KK, Jo HJ, Hong JP, et al (2008). Recombinant human epidermal growth factor accelerates recovery of mouse small intestinal mucosa after radiation damage. Int J Radiat Oncol Biol Phys, 71, 1230-5.
DOI
ScienceOn
|
21 |
Lee SW, Moon SY, Kim YH, Hong JP (2007b). The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer. Int Wound J, 4, 216-20.
DOI
ScienceOn
|
22 |
Leonardi MC, Gariboldi S, Ivaldi GB, et al (2008). A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis. Eur J Dermatol, 18, 317-21.
|
23 |
McQuestion M (2006). Evidence-based skin care management in radiation therapy. Semin Oncol Nurs, 22, 163-73.
DOI
ScienceOn
|
24 |
Merchant TE, Bosley C, Smith J, et al (2007). A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiat Oncol, 2, 45.
DOI
ScienceOn
|
25 |
Nanney LB (1990). Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol, 94, 624-9.
DOI
ScienceOn
|
26 |
Pommier P, Gomez F, Sunyach MP, et al (2004). Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol, 22, 1447-53.
DOI
ScienceOn
|
27 |
Ogce F, Okcin F, Yaren A, Demiray G (2013). Evaluation of quality of life of breast cancer patient next- of-kin in Turkey. Asian Pac J Cancer Prev, 14, 2771-6.
DOI
ScienceOn
|
28 |
Olascoaga A, Vilar-Compte D, Poitevin-Chacon A, Contreras-Ruiz J (2008). Wound healing in radiated skin: pathophysiology and treatment options. Int Wound J, 5, 246-57.
DOI
ScienceOn
|
29 |
Pinnix C, Perkins GH, Strom EA, et al (2012). Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys, 83, 1089-94.
DOI
ScienceOn
|
30 |
Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, et al (2008). Quality of life in breast cancer patients--a quantile regression analysis. Asian Pac J Cancer Prev, 9, 487-90.
|
31 |
Ryu SH, Kim YH, Lee SW, Hong JP (2010). The preventive effect of recombinant human growth factor (rhEGF) on the recurrence of radiodermatitis. J Radiat Res, 51, 511-7.
DOI
ScienceOn
|
32 |
Schmuth M, Wimmer MA, Hofer S, et al (2002). Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol, 146, 983-91.
DOI
ScienceOn
|
33 |
Tsang MW, Wong WK, Hung CS, et al (2003). Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care, 26, 1856-61.
DOI
ScienceOn
|
34 |
Tucker SL, Turesson I, Thames HD (1992). Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer, 28, 1783-91.
DOI
ScienceOn
|
35 |
Xie XX, Ouyang SY, Jin HK, et al (2012). Predictive value of XRCC1 gene polymorphisms for side effects in patients undergoing whole breast radiotherapy: a meta-analysis. Asian Pac J Cancer Prev, 13, 6121-8.
DOI
ScienceOn
|
36 |
Wells M, Macmillan M, Raab G, et al (2004). Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol, 73, 153-62.
DOI
ScienceOn
|
37 |
Williams MS, Burk M, Loprinzi CL, et al (1996). Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys, 36, 345-9.
|